&Partners’s Kyverna Therapeutics KYTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$88.8K Buy
+13,065
New +$103K ﹤0.01% 2614

Other funds holding KYTX

&Partners's KYTX Position: Q3 2026 in Review

&Partners opened a new position in Kyverna Therapeutics (KYTX) in Q3 2026: 13,065 shares worth $88.8K. The stake represents ﹤0.01% of the portfolio and ranks #2614 among its holdings.

128 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.

  • &Partners held 13,065 shares of Kyverna Therapeutics worth $88.8K as of Q3 2026.
  • Kyverna Therapeutics was a new &Partners position in Q3 2026.
  • Kyverna Therapeutics made up ﹤0.01% of &Partners's portfolio in Q3 2026, its #2614 holding.
  • 128 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.

Based on &Partners's 13F filing for Q3 2026, filed 16 Nov 2026.